The long-lasting sensitization of primary afferent nociceptors induced by inflammation involves prostanoid and dopaminergic systems in mice

Pharmacology Biochemistry and Behavior - Tập 103 - Trang 678-683 - 2013
Cristiane Flora Villarreal1, Mani Indiana Funez2, Fernando de Queiroz Cunha3, Carlos Amílcar Parada4, Sérgio Henrique Ferreira3
1Faculdade de Farmácia, Universidade Federal da Bahia, Barão de Jeremoabo Ondina, 40170-290 Salvador, Bahia, Brasil
2Faculdade de Enfermagem, Universidade de Brasília, QNN14 Área Especial, Ceilândia Sul, 72220-140, Ceilândia, Distrito Federal, Brasil
3Departamento de Farmacologia da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida Bandeirantes 3900, 14049-900, Ribeirão Preto, São Paulo, Brasil
4Instituto of Biologia, Universidade Estadual de Campinas, Rua Monteiro Lobato, 255, 13083-862, Campinas, São Paulo, Brasil

Tài liệu tham khảo

Aley, 2000, Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the e isozyme of protein kinase C, J Neurosci, 20, 4680, 10.1523/JNEUROSCI.20-12-04680.2000 Basbaum, 2009, Cellular and molecular mechanisms of pain, Cell, 139, 267, 10.1016/j.cell.2009.09.028 Bessou, 1969, Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli, J Neurophysiol, 32, 1025, 10.1152/jn.1969.32.6.1025 Bley, 1998, The role of IP prostanoid receptors in inflammatory pain, Trends Pharmacol Sci, 19, 141, 10.1016/S0165-6147(98)01185-7 Coderre, 1984, Effects of peripheral antisympathetic treatments in the tail-flick, formalin and autotomy tests, Pain, 18, 13, 10.1016/0304-3959(84)90122-2 Coleman, 1994, International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol Rev, 46, 205 Cunha, 1999, Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP-on inflammatory hyperalgesia, Br J Pharmacol, 127, 671, 10.1038/sj.bjp.0702601 Cunha, 2005, A cascade of cytokines mediates mechanical inflammatory hypernociception in mice, Proc Natl Acad Sci U S A, 102, 1755, 10.1073/pnas.0409225102 Dawson, 1991, A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse, Int J Tissue React, 13, 171 Di Rosa, 1972, Biological properties of carrageenan, J Pharm Pharmacol, 24, 89, 10.1111/j.2042-7158.1972.tb08940.x Duarte, 1988, Participation of the sympathetic system in acetic acid-induced writhing in mice, Braz J Med Biol Res, 21, 341 Ferreira, 1972, Prostaglandin, aspirin-like drugs and analgesia, Nat New Biol, 240, 200, 10.1038/newbio240200a0 Ferreira, 1979, I — prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process, Prostaglandins, 18, 179, 10.1016/0090-6980(79)90103-5 Ferreira, 1978, Central and peripheral antialgesic action of aspirin-like drugs, Eur J Pharmacol, 53, 39, 10.1016/0014-2999(78)90265-0 Ferreira, 1990, Induction, blockade and restoration of a persistent hypersensitive state, Pain, 42, 365, 10.1016/0304-3959(90)91149-D Gold, 2010, Nociceptor sensitization in pain pathogenesis, Nat Med, 16, 1248, 10.1038/nm.2235 Gold, 1996, Hyperalgesic agents increase a tetrodotoxin-resistant Na1 current in nociceptors, Proc Natl Acad Sci U S A, 93, 1108, 10.1073/pnas.93.3.1108 Gracely, 1992, Painful neuropathy: altered central processing maintained dynamically by peripheral input, Pain, 51, 175, 10.1016/0304-3959(92)90259-E Jacobson, 1989, Shoulder pain and repetition strain injury to the supraspinatus muscle: etiology and manipulative treatment, J Am Osteopath Assoc, 89, 1037, 10.1515/jom-1989-890813 Khasar, 1999, Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors, J Neurophysiol, 81, 1104, 10.1152/jn.1999.81.3.1104 Kissin, 2010, The development of new analgesics over the past 50years: a lack of real breakthrough drugs, Anesth Analg, 110, 780, 10.1213/ANE.0b013e3181cde882 Kuner, 2010, Central mechanisms of pathological pain, Nat Med, 16, 1258, 10.1038/nm.2231 Lin, 2006, Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity, J Pharmacol Exp Ther, 319, 1096, 10.1124/jpet.106.105569 MacIntyre, 1995, Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications, Sports Med, 20, 24, 10.2165/00007256-199520010-00003 McMahon, 2008, Inflammatory mediators and modulators of pain, 49 Melhorn, 1998, Cumulative trauma disorders and repetitive strain injuries. The future, Clin Orthop, 351, 107, 10.1097/00003086-199806000-00015 Memo, 1986, Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue, J Neural Transm Suppl, 22, 19 Missale, 1998, Dopamine receptors: from structure to function, Physiol Rev, 78, 189, 10.1152/physrev.1998.78.1.189 Monsma, 1990, Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation, Proc Natl Acad Sci U S A, 87, 6723, 10.1073/pnas.87.17.6723 Nakamura, 1987, A peripheral sympathetic component in inflammatory hyperalgesia, Eur J Pharmacol, 135, 145, 10.1016/0014-2999(87)90606-6 Nakao, 2007, CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties, J Pharmacol Exp Ther, 322, 686, 10.1124/jpet.107.122010 Ouseph, 1995, Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat, Neuroscience, 64, 769, 10.1016/0306-4522(94)00397-N Price, 2006, Peripheral and central contributions to hyperalgesia in irritable bowel syndrome, J Pain, 7, 529, 10.1016/j.jpain.2005.12.011 Price, 2009, Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging, Neuroimage, 47, 995, 10.1016/j.neuroimage.2009.04.028 Safieh-Garabedian, 2002, The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation, Neuropharmacology, 42, 864, 10.1016/S0028-3908(02)00028-X Staud, 2009, Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study, Pain, 145, 96, 10.1016/j.pain.2009.05.020 Sugimoto, 2007, Prostaglandin and receptors, J Biol Chem, 282, 11613, 10.1074/jbc.R600038200 Taiwo, 1991, Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia, Neuroscience, 44, 131, 10.1016/0306-4522(91)90255-M Taiwo, 1989, Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system, Neuroscience, 32, 577, 10.1016/0306-4522(89)90280-7 Turk, 1988, Toward an empirically derived taxonomy of chronic pain patients: integration of psychological assessment data, J Consult Clin Psychol, 56, 233, 10.1037/0022-006X.56.2.233 Verne, 2003, Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients, Pain, 105, 223, 10.1016/S0304-3959(03)00210-0 Villarreal, 2009, Acute and persistent nociceptive paw sensitisation in mice: the involvement of distinct signalling pathways, Life Sci, 85, 822, 10.1016/j.lfs.2009.10.018 Villena, 1999, Ocular inflammation models by topical application: croton-oil induced uveitis, Curr Eye Res, 18, 3, 10.1076/ceyr.18.1.3.5395 Wall, 1974, Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating from a neuroma, Exp Neurol, 43, 580, 10.1016/0014-4886(74)90197-6 Zimmermann, 1983, Ethical guidelines for investigations of experimental pain in conscious animals, Pain, 16, 109, 10.1016/0304-3959(83)90201-4